Dermata Therapeutics, Inc.
USD1.27
-0.09 (-6.62%)
CEO
Gerald T. Proehl
IPO Date
2021-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.33
Prev. Close
$1.36
Day Low
$1.23
Day High
$1.34
52W Low
$1.10
52W High
$8.00
Market Cap
$0.00B
Volume
0.08M
| 37,500 |
| $2.18 |
| 6 Jan 2026 | WIERENGA WENDELL | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | HALE DAVID F | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | A-Award | Acquired | 9,000 | $2.18 |
| 6 Jan 2026 | Scott Kathleen D. | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | Nardo Christopher J. | Senior VP, CDO | A-Award | Acquired | 18,000 | $2.18 |
| 6 Jan 2026 | Sandler Andrew Seth | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | Van Hoose Kyri K. | SVP, CFO | A-Award | Acquired | 18,000 | $2.18 |
| 6 Jan 2026 | Mento Steven J | director | A-Award | Acquired | 2,500 | $2.18 |